RIGI and viral infectious disease: The amplification of the antiviral RIG-I pathway by RNAse L was initially identified by Malathi and colleagues in the context of a viral infection [42], but our data are the first demonstration, to our knowledge, that the activation of the OAS-RNase L axis may occur in the absence of pathogen.